Form 4: IBEX Ltd Director Sells 11,199 Shares in Open Market Transaction
SEC Form 4 Filing
A director of IBEX Ltd, Shuja Keen, sold 11,199 common shares at a weighted average price of $21.9522 per share on December 30, 2024.
Summary
- Shuja Keen, a director of IBEX Ltd, sold 11,199 common shares on December 30, 2024.
- The shares were sold at a weighted average price of $21.9522 per share.
- The sale was executed in multiple trades with prices ranging from $21.95 to $21.96.
- Following the transaction, Shuja Keen beneficially owns 47,727 shares indirectly through Adia Global LLC.
Sentiment
Score: 5
Explanation: The document is a neutral disclosure of a share sale by a director, which is a routine event. There is no indication of positive or negative sentiment.
Industry Context
This is a standard Form 4 filing, which is a routine disclosure of insider transactions. It does not indicate any specific trend in the industry but is a normal part of corporate governance.
Comparison to Industry Standards
- Form 4 filings are a standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading disclosures.
- The sale of shares by a director is a common occurrence and does not necessarily indicate a negative outlook for the company.
Stakeholder Impact
- The share sale by a director may have a minor impact on shareholder sentiment, but it is a routine transaction and not likely to cause significant concern.
Key Dates
| Date | Description |
|---|---|
| 12/30/2024 | Date of the share sale transaction. |
Keywords
IBEX Ltd, director, share sale, insider trading, Form 4, equity securities, Shuja Keen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.